AI assistant
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2016
Jun 27, 2016
33148_dirs_2016-06-27_5967df7e-e2db-4f2c-be23-cd468c2afae4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2016-06-23
Reporting Person: CARROLL J MARTIN (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-23 | Stock Options (Right to Buy) | $7.61 | A | 12000 | Acquired | 2026-06-22 | Common Stock (12000) | Direct |
| 2016-06-23 | Stock Options (Right to Buy) | $7.61 | A | 51000 | Acquired | 2026-06-22 | Common Stock (51000) | Direct |
Footnotes
F1: This stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. The option shall vest in equal quarterly installments at the end of each quarter following June 23, 2016, subject to continued service through such dates.
F2: This stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. The option shall vest as follows: 25% of the shares shall be vested on June 23, 2017 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter so long as the Reporting Person is a director of the Issuer on such date.